Cytokinetics, Incorporated (CYTK)
USD 38.79
(2.47%)
USD 38.79
(2.47%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -496.2 Million USD | -53.05% |
| 2022 | -324.2 Million USD | -74.01% |
| 2021 | -186.31 Million USD | -98.33% |
| 2020 | -93.94 Million USD | 4.98% |
| 2019 | -98.86 Million USD | -11.19% |
| 2018 | -88.91 Million USD | 21.59% |
| 2017 | -113.39 Million USD | -706.82% |
| 2016 | 18.68 Million USD | 149.96% |
| 2015 | -37.4 Million USD | -153.54% |
| 2014 | -14.75 Million USD | 56.47% |
| 2013 | -33.89 Million USD | 13.32% |
| 2012 | -39.1 Million USD | 18.48% |
| 2011 | -47.96 Million USD | 3.37% |
| 2010 | -49.63 Million USD | -290.21% |
| 2009 | 26.09 Million USD | 144.17% |
| 2008 | -59.07 Million USD | -4.59% |
| 2007 | -56.48 Million USD | 7.91% |
| 2006 | -61.33 Million USD | -37.43% |
| 2005 | -44.63 Million USD | -16.13% |
| 2004 | -38.43 Million USD | -17.93% |
| 2003 | -32.59 Million USD | -35.9% |
| 2002 | -23.98 Million USD | -30.39% |
| 2001 | -18.39 Million USD | -33.34% |
| 2000 | -13.79 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -126.23 Million USD | 0.93% |
| 2024 Q2 | -130.17 Million USD | -3.12% |
| 2023 Q2 | -122.04 Million USD | 1.95% |
| 2023 Q1 | -124.47 Million USD | 2.01% |
| 2023 Q4 | -127.41 Million USD | -4.21% |
| 2023 FY | -496.2 Million USD | -53.05% |
| 2023 Q3 | -122.26 Million USD | -0.18% |
| 2022 Q3 | -108.44 Million USD | -897.25% |
| 2022 Q4 | -127.03 Million USD | -17.14% |
| 2022 Q1 | -77.85 Million USD | -258.72% |
| 2022 FY | -324.2 Million USD | -74.01% |
| 2022 Q2 | -10.87 Million USD | 86.03% |
| 2021 Q2 | -54.79 Million USD | -34.93% |
| 2021 Q3 | -69.2 Million USD | -26.29% |
| 2021 Q4 | -21.7 Million USD | 68.64% |
| 2021 FY | -186.31 Million USD | -98.33% |
| 2021 Q1 | -40.61 Million USD | -11.55% |
| 2020 Q2 | -32.35 Million USD | -6.57% |
| 2020 Q3 | 5.18 Million USD | 116.02% |
| 2020 FY | -93.94 Million USD | 4.98% |
| 2020 Q4 | -36.4 Million USD | -802.3% |
| 2020 Q1 | -30.36 Million USD | -28.08% |
| 2019 Q4 | -23.7 Million USD | 0.92% |
| 2019 Q1 | -24.51 Million USD | -14.26% |
| 2019 FY | -98.86 Million USD | -11.19% |
| 2019 Q2 | -26.71 Million USD | -8.96% |
| 2019 Q3 | -23.92 Million USD | 10.44% |
| 2018 Q1 | -26.13 Million USD | 28.46% |
| 2018 Q2 | -23.41 Million USD | 10.4% |
| 2018 Q3 | -17.91 Million USD | 23.49% |
| 2018 Q4 | -21.45 Million USD | -19.79% |
| 2018 FY | -88.91 Million USD | 21.59% |
| 2017 Q2 | -25.19 Million USD | -8.36% |
| 2017 FY | -113.39 Million USD | -706.82% |
| 2017 Q3 | -28.42 Million USD | -12.82% |
| 2017 Q1 | -23.25 Million USD | -402.43% |
| 2017 Q4 | -36.52 Million USD | -28.51% |
| 2016 Q2 | -11.01 Million USD | 7.89% |
| 2016 Q1 | -11.95 Million USD | -32.51% |
| 2016 FY | 18.68 Million USD | 149.96% |
| 2016 Q3 | 32.49 Million USD | 395.07% |
| 2016 Q4 | 7.68 Million USD | -76.34% |
| 2015 Q4 | -9.02 Million USD | -1.5% |
| 2015 FY | -37.4 Million USD | -153.54% |
| 2015 Q3 | -8.88 Million USD | 16.06% |
| 2015 Q2 | -10.58 Million USD | -18.86% |
| 2015 Q1 | -8.9 Million USD | -205.8% |
| 2014 Q3 | -5.99 Million USD | 28.65% |
| 2014 Q4 | 8.42 Million USD | 240.4% |
| 2014 Q1 | -8.77 Million USD | -236.35% |
| 2014 FY | -14.75 Million USD | 56.47% |
| 2014 Q2 | -8.4 Million USD | 4.14% |
| 2013 Q3 | -12.61 Million USD | 16.31% |
| 2013 FY | -33.89 Million USD | 13.32% |
| 2013 Q4 | 6.43 Million USD | 151.0% |
| 2013 Q2 | -15.06 Million USD | -19.14% |
| 2013 Q1 | -12.64 Million USD | -24.81% |
| 2012 Q3 | -10.07 Million USD | -12.47% |
| 2012 Q4 | -10.13 Million USD | -0.6% |
| 2012 FY | -39.1 Million USD | 18.48% |
| 2012 Q1 | -9.94 Million USD | 16.45% |
| 2012 Q2 | -8.95 Million USD | 9.9% |
| 2011 Q1 | -11.75 Million USD | -1.03% |
| 2011 Q2 | -13.64 Million USD | -16.12% |
| 2011 Q3 | -10.66 Million USD | 21.83% |
| 2011 Q4 | -11.89 Million USD | -11.52% |
| 2011 FY | -47.96 Million USD | 3.37% |
| 2010 Q4 | -11.63 Million USD | 7.43% |
| 2010 FY | -49.63 Million USD | -290.21% |
| 2010 Q1 | -12.28 Million USD | 0.94% |
| 2010 Q2 | -13.15 Million USD | -7.09% |
| 2010 Q3 | -12.56 Million USD | 4.48% |
| 2009 Q3 | -8.2 Million USD | -114.26% |
| 2009 Q4 | -12.4 Million USD | -51.07% |
| 2009 FY | 26.09 Million USD | 144.17% |
| 2009 Q1 | -10.84 Million USD | 2.67% |
| 2009 Q2 | 57.54 Million USD | 630.71% |
| 2008 Q3 | -16.71 Million USD | -4.21% |
| 2008 Q1 | -15.19 Million USD | -1.55% |
| 2008 FY | -59.07 Million USD | -4.59% |
| 2008 Q4 | -11.14 Million USD | 33.34% |
| 2008 Q2 | -16.03 Million USD | -5.58% |
| 2007 FY | -56.48 Million USD | 7.91% |
| 2007 Q4 | -14.95 Million USD | -13.32% |
| 2007 Q3 | -13.2 Million USD | 9.37% |
| 2007 Q2 | -14.56 Million USD | -5.81% |
| 2007 Q1 | -13.76 Million USD | 18.94% |
| 2006 Q1 | -13.46 Million USD | -15.15% |
| 2006 Q3 | -16 Million USD | -7.47% |
| 2006 Q4 | -16.98 Million USD | -6.12% |
| 2006 FY | -61.33 Million USD | -37.43% |
| 2006 Q2 | -14.88 Million USD | -10.55% |
| 2005 Q2 | -11.1 Million USD | 0.06% |
| 2005 Q3 | -10.72 Million USD | 3.35% |
| 2005 FY | -44.63 Million USD | -16.13% |
| 2005 Q4 | -11.69 Million USD | -9.01% |
| 2005 Q1 | -11.1 Million USD | 9.62% |
| 2004 Q2 | -9.52 Million USD | -59.53% |
| 2004 Q3 | -10.65 Million USD | -11.91% |
| 2004 Q1 | -5.96 Million USD | 85.27% |
| 2004 Q4 | -12.29 Million USD | -15.34% |
| 2004 FY | -38.43 Million USD | -17.93% |
| 2003 Q1 | -7.13 Million USD | 0.0% |
| 2003 FY | -32.59 Million USD | -35.9% |
| 2003 Q4 | -40.52 Million USD | -1632.64% |
| 2003 Q3 | 2.64 Million USD | 134.02% |
| 2003 Q2 | -7.77 Million USD | -9.0% |
| 2002 FY | -23.98 Million USD | -30.39% |
| 2001 FY | -18.39 Million USD | -33.34% |
| 2000 FY | -13.79 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Caribou Biosciences, Inc. | -116.05 Million USD | -327.545% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -2369.936% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1348.055% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -878.843% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -196.575% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -256.902% |
| Agenus Inc. | -159.54 Million USD | -211.005% |
| Fortress Biotech, Inc. | -142.34 Million USD | -248.601% |
| GlycoMimetics, Inc. | -39.27 Million USD | -1163.402% |
| Novavax, Inc. | -566.51 Million USD | 12.41% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -191.987% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -41527.936% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -413.086% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -15592.758% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -972.737% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -75.85% |
| AlloVir, Inc. | -181.33 Million USD | -173.646% |
| Aptorum Group Limited | -10.52 Million USD | -4615.285% |
| Ardelyx, Inc. | -63.27 Million USD | -684.191% |
| Bicycle Therapeutics plc | -189.94 Million USD | -161.235% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -188.857% |
| Chimerix, Inc. | -93.06 Million USD | -433.181% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -1000.787% |
| CRISPR Therapeutics AG | -222.53 Million USD | -122.975% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1897.283% |
| Precision BioSciences, Inc. | -43.73 Million USD | -1034.546% |
| Dyadic International, Inc. | -8.22 Million USD | -5929.414% |
| Elevation Oncology, Inc. | -45.44 Million USD | -991.88% |
| Fortress Biotech, Inc. | -142.34 Million USD | -248.601% |
| GT Biopharma, Inc. | -13.57 Million USD | -3555.016% |
| Alkermes plc | 414.12 Million USD | 219.821% |
| Immix Biopharma, Inc. | -16.14 Million USD | -2974.168% |
| Innoviva, Inc. | 176.7 Million USD | 380.803% |
| IO Biotech, Inc. | -91.44 Million USD | -442.639% |
| Jaguar Health, Inc. | -34.29 Million USD | -1347.041% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 4255.125% |
| ContextLogic Inc. | -328 Million USD | -51.282% |
| AbCellera Biologics Inc. | -237.2 Million USD | -109.186% |
| Lantern Pharma Inc. | -17.87 Million USD | -2675.573% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -5737.019% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -142.049% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -30.41% |
| MEI Pharma, Inc. | 14.54 Million USD | 3512.22% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -491.326% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1941.441% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -277.385% |
| NextCure, Inc. | -67.63 Million USD | -633.63% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -407.918% |
| ChromaDex Corporation | -5.59 Million USD | -8762.386% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -269.121% |
| Incyte Corporation | 620.52 Million USD | 179.965% |
| Opthea Limited | -191.84 Million USD | -158.652% |
| MiMedx Group, Inc. | 37.11 Million USD | 1436.903% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -834.009% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -589.816% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -17931.852% |
| Vaxcyte, Inc. | -468.04 Million USD | -6.017% |
| PDS Biotechnology Corporation | -43.04 Million USD | -1052.752% |
| Pharming Group N.V. | -4.87 Million USD | -10069.085% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1567.58% |
| Onconetix, Inc. | -36.03 Million USD | -1277.024% |
| Acelyrin, Inc. | -422.06 Million USD | -17.566% |
| PureTech Health plc | -146.19 Million USD | -239.404% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -503.685% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -110.615% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -2455.319% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1941.441% |
| ESSA Pharma Inc. | -32.13 Million USD | -1444.169% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -2321.575% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -4597.576% |
| Seer, Inc. | -103.46 Million USD | -379.597% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -81.093% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -1210.32% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1593.243% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -3847959.782% |
| Summit Therapeutics Inc. | -89.73 Million USD | -452.961% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -1238.779% |
| Senti Biosciences, Inc. | -92.72 Million USD | -435.125% |
| ImmuCell Corporation | -5.74 Million USD | -8532.538% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -284.691% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -579.928% |
| Precigen, Inc. | -88.92 Million USD | -458.016% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -774.231% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -1089.541% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -332.336% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -1027.482% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -12487.493% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 1.608% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -654.581% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1402.695% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1595.963% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -2729.152% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -629.756% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -160.46% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -7093.462% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -126.349% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 671.586% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -863.393% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -4893.185% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -91.099% |
| Aptose Biosciences Inc. | -52.35 Million USD | -847.752% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -3340.904% |
| Soligenix, Inc. | -7.69 Million USD | -6345.945% |
| Century Therapeutics, Inc. | -146.54 Million USD | -238.6% |
| Kura Oncology, Inc. | -165.8 Million USD | -199.272% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -430.939% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -5864.719% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -19895.052% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -7552.761% |
| Autolus Therapeutics plc | -195.02 Million USD | -154.428% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -486.136% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -573.624% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -2247.788% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -118.559% |
| GRI Bio, Inc. | -11.38 Million USD | -4257.645% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -10888.404% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -278.225% |
| IGM Biosciences, Inc. | -263.46 Million USD | -88.341% |
| INmune Bio, Inc. | -29.74 Million USD | -1568.421% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -348.587% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1203.22% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -3005.287% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -3046.347% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -712.146% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -361.492% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -79.781% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -144.197% |
| Verastem, Inc. | -92.08 Million USD | -438.861% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -952.732% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -169.464% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -319.163% |
| Histogen Inc. | -10.64 Million USD | -4562.266% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -3107.124% |
| Surrozen, Inc. | -45.78 Million USD | -983.89% |
| Organovo Holdings, Inc. | -15.08 Million USD | -3189.175% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -9648.173% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -737.032% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -867.374% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1862.836% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -6400.92% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -189.699% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -924.202% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -534.493% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -3160.051% |
| Apollomics, Inc. | -54.83 Million USD | -804.922% |
| Amarin Corporation plc | -67.58 Million USD | -634.161% |
| Mesoblast Limited | -58.79 Million USD | -743.972% |
| Turnstone Biologics Corp. | -59.03 Million USD | -740.57% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -199.767% |
| Synaptogenix, Inc. | -8.31 Million USD | -5868.411% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -3301.927% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -441.171% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10256.016% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -5518.75% |
| Exelixis, Inc. | 170.88 Million USD | 390.374% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1196.861% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -220.002% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 4.045% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4102.612% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -6070.241% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1554.403% |
| Gritstone bio, Inc. | -154.63 Million USD | -220.89% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -620.589% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -2797.877% |
| Avid Bioservices, Inc. | -18.67 Million USD | -2556.628% |
| Insmed Incorporated | -709.62 Million USD | 30.075% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -3062.599% |
| MediWound Ltd. | -15.29 Million USD | -3145.291% |
| OmniAb, Inc. | -69.41 Million USD | -614.797% |
| Alector, Inc. | -151.74 Million USD | -227.01% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -359.521% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -851.532% |
| Zai Lab Limited | -366.57 Million USD | -35.363% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -56.642% |
| Aura Biosciences, Inc. | -84.99 Million USD | -483.832% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -102.121% |
| Immunic, Inc. | -99.22 Million USD | -400.091% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -246.614% |
| Veracyte, Inc. | -85.79 Million USD | -478.361% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -76.075% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3391.942% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -7103.961% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -2540.425% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 185.763% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1849.495% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1378.813% |
| TG Therapeutics, Inc. | 20.63 Million USD | 2504.91% |
| Galecto, Inc. | -39.9 Million USD | -1143.466% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -1079.363% |
| Fortrea Holdings Inc. | 63.1 Million USD | 886.379% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -253.309% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1618.28% |
| XBiotech Inc. | -37.51 Million USD | -1222.861% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -620.589% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -639.28% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -359.849% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1832.865% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -831.106% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 12.825% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -532.173% |
| Vaxxinity, Inc. | -58.28 Million USD | -751.343% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -378.459% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -2129.821% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -474.205% |
| NexImmune, Inc. | -29.19 Million USD | -1599.77% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -8729.063% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -3303.005% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 112.261% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1849.036% |
| Scopus BioPharma Inc. | -11.71 Million USD | -4135.683% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -290.522% |
| Ainos, Inc. | -13.2 Million USD | -3657.308% |
| Pluri Inc. | -22.15 Million USD | -2139.394% |
| Prothena Corporation plc | -191.03 Million USD | -159.744% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -259.47% |
| Celularity Inc. | -192.28 Million USD | -158.054% |
| Rallybio Corporation | -78.93 Million USD | -528.649% |
| Cue Biopharma, Inc. | -52.14 Million USD | -851.514% |
| MeiraGTx Holdings plc | -137.06 Million USD | -262.032% |
| Omeros Corporation | -164.53 Million USD | -201.589% |
| Humacyte, Inc. | -100.04 Million USD | -395.972% |
| Immunocore Holdings plc | -59.64 Million USD | -731.875% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -2573.662% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -1926.733% |
| Blueprint Medicines Corporation | -486.27 Million USD | -2.042% |
| CalciMedica, Inc. | -21.87 Million USD | -2168.366% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -564.62% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -189.679% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -51.791% |
| Pulmatrix, Inc. | -14.74 Million USD | -3266.384% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -1288.18% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -458.374% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 3.704% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -634.564% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -1341.66% |
| Nutriband Inc. | -4.87 Million USD | -10084.986% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -1037.746% |
| Vor Biopharma Inc. | -126.03 Million USD | -293.701% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 111.697% |
| Evogene Ltd. | -26.39 Million USD | -1780.205% |
| ProKidney Corp. | -151.52 Million USD | -227.48% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -668.893% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -6350.72% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 18.303% |
| CorMedix Inc. | -48.95 Million USD | -913.536% |
| BioLineRx Ltd. | -49.69 Million USD | -898.521% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -334.608% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -1203.333% |
| Atai Life Sciences N.V. | -125.47 Million USD | -295.474% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -507.802% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -509.521% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -99.289% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1514.2% |
| MediciNova, Inc. | -9.9 Million USD | -4912.038% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -292.651% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -6751.333% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1755.462% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -114.043% |
| Biomea Fusion, Inc. | -126.13 Million USD | -293.392% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -42.016% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1646.217% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -159.672% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -115.784% |
| Absci Corporation | -115.51 Million USD | -329.559% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1698.691% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -339.637% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -104.906% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1869.38% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -138.567% |
| Allakos Inc. | -196.05 Million USD | -153.094% |
| Imunon, Inc. | -21.03 Million USD | -2259.462% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -348.389% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 562.524% |
| BioAtla, Inc. | -129.68 Million USD | -282.617% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4102.612% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -3032.014% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -51.403% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -1088.287% |
| XOMA Corporation | -41.84 Million USD | -1085.732% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -371.512% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -308.416% |
| aTyr Pharma, Inc. | -54.91 Million USD | -803.522% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -467.565% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -187.039% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -95.011% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -2211.586% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -5941.882% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2852.547% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5611155.418% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 246.991% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -7494.174% |
| UroGen Pharma Ltd. | -65.53 Million USD | -657.149% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -455.798% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -6731.945% |
| Orgenesis Inc. | -53.63 Million USD | -825.134% |
| Entera Bio Ltd. | -8.89 Million USD | -5480.981% |
| GH Research PLC | -41.22 Million USD | -1103.738% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -1830.158% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -497.456% |
| Xencor, Inc. | -138.63 Million USD | -257.912% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -9526.482% |
| Replimune Group, Inc. | -234.77 Million USD | -111.355% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -2208.884% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -3456.515% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -7494.174% |
| Portage Biotech Inc. | -18.25 Million USD | -2618.485% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -6751.333% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -372.752% |
| OncoCyte Corporation | -25.13 Million USD | -1874.081% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -4289.308% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -4230.997% |
| Purple Biotech Ltd. | 22.27 Million USD | 2328.032% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -6505.498% |
| scPharmaceuticals Inc. | -55.39 Million USD | -795.742% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -2525.744% |
| HilleVax, Inc. | -133.34 Million USD | -272.121% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -4018.226% |
| Tharimmune, Inc. | -9.45 Million USD | -5147.948% |
| Genprex, Inc. | -31.07 Million USD | -1496.769% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -163.667% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1481.429% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -64763.399% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -9009.829% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3150461.946% |
| Savara Inc. | -60 Million USD | -726.912% |
| Curis, Inc. | -48.33 Million USD | -926.659% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1508.972% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -9410.799% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -6718.813% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1720.936% |
| BeiGene, Ltd. | -1.2 Billion USD | 58.914% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -2388.578% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | -1.851% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -429.839% |
| Erasca, Inc. | -141.52 Million USD | -250.613% |
| bluebird bio, Inc. | -244.26 Million USD | -103.145% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -10861.075% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 355.196% |
| DBV Technologies S.A. | -76.43 Million USD | -549.211% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -10861.075% |
| Moderna, Inc. | -4.23 Billion USD | 88.294% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1064.554% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -7701.965% |
| Molecular Templates, Inc. | -10.46 Million USD | -4641.114% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -637.994% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -31.709% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -246.243% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -854.369% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -221.081% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -138.411% |
| MacroGenics, Inc. | -168.24 Million USD | -194.932% |
| RenovoRx, Inc. | -11.39 Million USD | -4254.203% |
| Adicet Bio, Inc. | -152.03 Million USD | -226.369% |
| Prime Medicine, Inc. | -191.29 Million USD | -159.397% |
| Aditxt, Inc. | -26.06 Million USD | -1803.91% |
| Adagene Inc. | -23.71 Million USD | -1991.938% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6687.939% |
| Quantum-Si incorporated | -111.17 Million USD | -346.344% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1467.887% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3303.848% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 506.679% |
| SciSparc Ltd. | -5.77 Million USD | -8495.271% |
| Vericel Corporation | -6.46 Million USD | -7576.439% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5632.058% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -2046.255% |
| Generation Bio Co. | -138.56 Million USD | -258.108% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -497.621% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -473.913% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -105.808% |
| Invivyd, Inc. | -207.78 Million USD | -138.809% |
| Relay Therapeutics, Inc. | -373 Million USD | -33.031% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -5190.876% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 2409.972% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4723.612% |
| 2seventy bio, Inc. | -216.7 Million USD | -128.979% |
| ADMA Biologics, Inc. | 21.63 Million USD | 2393.847% |
| Clene Inc. | -40.54 Million USD | -1123.989% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1960.835% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -805.55% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1755.462% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -41.749% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -1250.879% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 3186.428% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -378.491% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1359.341% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -191.409% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 27.488% |
| Evaxion Biotech A/S | -22.19 Million USD | -2135.46% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -502.322% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -122.39% |
| Trevena, Inc. | -35.28 Million USD | -1306.158% |
| Surrozen, Inc. | -45.78 Million USD | -983.89% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -520.683% |
| Cingulate Inc. | -22.75 Million USD | -2080.24% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 6723.131% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -1010.898% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -5926.337% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -383.829% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -576.222% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -699.377% |
| Clearmind Medicine Inc. | -8.74 Million USD | -5576.526% |
| Kronos Bio, Inc. | -121.83 Million USD | -307.293% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -551.222% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -16818.089% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -392.135% |
| Statera Biopharma, Inc. | -98.34 Million USD | -404.562% |
| ImmunityBio, Inc. | -362.25 Million USD | -36.979% |
| Korro Bio, Inc. | -84.53 Million USD | -486.989% |
| Kineta, Inc. | -15.72 Million USD | -3055.918% |
| BioVie Inc. | -32.17 Million USD | -1441.987% |
| Codexis, Inc. | -68.06 Million USD | -628.974% |
| Celularity Inc. | -192.28 Million USD | -158.054% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -122.905% |
| Celcuity Inc. | -66.23 Million USD | -649.211% |
| Virax Biolabs Group Limited | -6.49 Million USD | -7538.068% |
| Cibus, Inc. | -318.88 Million USD | -55.607% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -1053.965% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1366.154% |
| IN8bio, Inc. | -30.33 Million USD | -1535.643% |
| Kodiak Sciences Inc. | -277.32 Million USD | -78.928% |
| Annexon, Inc. | -143.72 Million USD | -245.251% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -300.841% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -667.573% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -2016.554% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -40.278% |
| Eyenovia, Inc. | -25.4 Million USD | -1853.067% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1620.236% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -8821.341% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -527.052% |
| Arcellx, Inc. | -89.88 Million USD | -452.075% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -992.674% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -261.647% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1495.053% |
| Moolec Science SA | -6.65 Million USD | -7357.462% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -711.615% |
| Geron Corporation | -193.94 Million USD | -155.85% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -1047.215% |
| Royalty Pharma plc | 1.49 Billion USD | 133.254% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -202.265% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -5219.598% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -2166.329% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -190.251% |
| Humacyte, Inc. | -100.04 Million USD | -395.972% |
| Structure Therapeutics Inc. | -102.77 Million USD | -382.807% |
| 89bio, Inc. | -151.2 Million USD | -228.169% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -519.235% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -3312.689% |
| Genelux Corporation | -24.16 Million USD | -1953.404% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1362.739% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -188.911% |
| Notable Labs, Ltd. | -14.65 Million USD | -3285.447% |
| Liquidia Corporation | -73.38 Million USD | -576.176% |
| Mustang Bio, Inc. | -50.72 Million USD | -878.206% |
| Immunovant, Inc. | -282.7 Million USD | -75.518% |
| Quantum-Si incorporated | -111.17 Million USD | -346.344% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -535.321% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -2233.216% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -386.418% |
| Acasti Pharma Inc. | -11.31 Million USD | -4286.536% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -2064.839% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -3005.287% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -131.813% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -13423.992% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -3023.536% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1601.838% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -1099.026% |
| PepGen Inc. | -84.76 Million USD | -485.382% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1574.614% |
| United Therapeutics Corporation | 1.18 Billion USD | 141.877% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2067.118% |
| Solid Biosciences Inc. | -104.31 Million USD | -375.679% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1412.446% |
| Immuneering Corporation | -58.41 Million USD | -749.479% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -9648.173% |
| Silo Pharma, Inc. | -3.85 Million USD | -12769.749% |
| Belite Bio, Inc | -31.66 Million USD | -1466.897% |
| XOMA Corporation | -41.84 Million USD | -1085.732% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -634.901% |
| Bionomics Limited | -17.89 Billion USD | 97.227% |
| Apogee Therapeutics, Inc. | -93 Million USD | -433.537% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1490.709% |
| uniQure N.V. | -282.87 Million USD | -75.417% |
| Cassava Sciences, Inc. | -105.95 Million USD | -368.308% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6687.939% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -283.158% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1427.443% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -5872.074% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1588.059% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -8821.341% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3391.942% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -5482.236% |
| Altimmune, Inc. | -95.92 Million USD | -417.263% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -575.164% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1490.709% |
| Compugen Ltd. | -12.99 Million USD | -3719.312% |
| Peak Bio, Inc. | -1356.23 USD | -36586983.312% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -900.333% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2106.336% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -104.787% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1568.14% |
| Zura Bio Limited | -62.63 Million USD | -692.179% |
| PolyPid Ltd. | -22.86 Million USD | -2069.961% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -2948.691% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1568.14% |
| Instil Bio, Inc. | -159.16 Million USD | -211.747% |
| argenx SE | -425.04 Million USD | -16.741% |
| Immunome, Inc. | -109.53 Million USD | -353.031% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -885.257% |
| Verona Pharma plc | -67.83 Million USD | -631.532% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -1804.087% |
| Shattuck Labs, Inc. | -91.95 Million USD | -439.605% |
| CervoMed Inc. | -7.81 Million USD | -6251.103% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -578.71% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -3624.983% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -930.027% |
| Moolec Science SA | -6.65 Million USD | -7357.462% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -2916.73% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -266.943% |
| AnaptysBio, Inc. | -164.41 Million USD | -201.808% |
| Design Therapeutics, Inc. | -78.19 Million USD | -534.614% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -470.082% |
| NeurAxis, Inc. | -6.66 Million USD | -7345.5% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -1125.228% |
| Lumos Pharma, Inc. | -36.61 Million USD | -1255.233% |
| Achilles Therapeutics plc | -75.25 Million USD | -559.365% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -1804.087% |
| 180 Life Sciences Corp. | -13.47 Million USD | -3581.729% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 9723.256% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -16818.089% |
| Nutriband Inc. | -4.87 Million USD | -10084.986% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -347.919% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -794.885% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -876.09% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -650.7% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -816.808% |
| Palisade Bio, Inc. | -13.07 Million USD | -3696.519% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -992.746% |
| Beam Therapeutics Inc. | -176.48 Million USD | -181.16% |
| Neurogene Inc. | -55.58 Million USD | -792.728% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -354.592% |
| AEON Biopharma, Inc. | -48.42 Million USD | -924.603% |
| Sesen Bio, Inc. | -25.9 Million USD | -1815.184% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -494.051% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -3842.235% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -7.74% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -584.997% |
| Athira Pharma, Inc. | -125.46 Million USD | -295.49% |
| Vaccinex, Inc. | -22.88 Million USD | -2068.254% |
| HCW Biologics Inc. | -25.71 Million USD | -1829.47% |
| XOMA Corporation | -41.84 Million USD | -1085.732% |
| Nektar Therapeutics | -137.42 Million USD | -261.073% |
| Arvinas, Inc. | -401.5 Million USD | -23.588% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5611155.418% |
| Merus N.V. | -156.54 Million USD | -216.969% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -394.913% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1333.29% |
| Rezolute, Inc. | -70.42 Million USD | -604.606% |
| Clene Inc. | -40.54 Million USD | -1123.989% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -2929.617% |
| BeyondSpring Inc. | -23.11 Million USD | -2046.773% |
| Synlogic, Inc. | -55.16 Million USD | -799.558% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -2667.611% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4484.303% |
| Peak Bio, Inc. | -1356.23 USD | -36586983.312% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -1125.107% |
| Krystal Biotech, Inc. | -109.72 Million USD | -352.218% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -283.052% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -44.661% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -10355.329% |
| MannKind Corporation | 8.67 Million USD | 5817.965% |
| Ikena Oncology, Inc. | -75.41 Million USD | -557.948% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -5043.62% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -638.071% |
| Gossamer Bio, Inc. | -183.75 Million USD | -170.03% |
| CohBar, Inc. | -12.38 Million USD | -3905.434% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -878.245% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1698.691% |
| Legend Biotech Corporation | -439.48 Million USD | -12.906% |
| Mural Oncology plc | -194.63 Million USD | -154.937% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -639.027% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2973.377% |
| Disc Medicine, Inc. | -91.12 Million USD | -444.532% |
| Champions Oncology, Inc. | -7.35 Million USD | -6645.582% |
| REGENXBIO Inc. | -268.12 Million USD | -85.063% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -4529.561% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -789.958% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -1173.606% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -333.909% |
| Vaxart, Inc. | -83.34 Million USD | -495.348% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -5723.997% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -1059.518% |
| Cellectis S.A. | -106.62 Million USD | -365.37% |
| Longeveron Inc. | -21.02 Million USD | -2259.622% |
| Repare Therapeutics Inc. | -116.22 Million USD | -326.938% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -85.273% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -555.965% |
| Revolution Medicines, Inc. | -487.18 Million USD | -1.851% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -7359.486% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -1028.919% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -565.243% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -612.58% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -4406.448% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 111.52% |
| Denali Therapeutics Inc. | -196.69 Million USD | -152.266% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5632.058% |
| Veru Inc. | -93.78 Million USD | -429.104% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -2026.988% |
| Cingulate Inc. | -22.75 Million USD | -2080.24% |
| Passage Bio, Inc. | -108.38 Million USD | -357.8% |
| Context Therapeutics Inc. | -25.07 Million USD | -1879.072% |
| Exicure, Inc. | -14.99 Million USD | -3208.916% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -140.801% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -1122.24% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -5006.599% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -169.154% |
| Nuvalent, Inc. | -149.49 Million USD | -231.927% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -5939.122% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -459.224% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -2288.587% |
| OmniAb, Inc. | -69.41 Million USD | -614.797% |
| Anew Medical, Inc. | -1.3 Million USD | -38044.968% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -3785.404% |
| Lipocine Inc. | -17.93 Million USD | -2667.309% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -624.249% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -551.598% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1203.22% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -1155.357% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -2116.784% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 14.425% |
| Ocugen, Inc. | -65.53 Million USD | -657.207% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -428.631% |
| Q32 Bio Inc. | -92.1 Million USD | -438.756% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -2214.497% |
| Alumis Inc. Common Stock | -158.17 Million USD | -213.708% |
| Equillium, Inc. | -14.52 Million USD | -3316.919% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -695.124% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -6178.414% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2530.279% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -956.857% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -357.475% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -4045.4% |
| Dominari Holdings Inc. | -21.79 Million USD | -2176.587% |
| Edesa Biotech, Inc. | -9.22 Million USD | -5280.224% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1845.749% |
| Bio-Techne Corporation | 206.68 Million USD | 340.077% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -26.749% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 358.4% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -275.126% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -1192.503% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -228.393% |
| Nkarta, Inc. | -131.65 Million USD | -276.912% |
| BioCardia, Inc. | -11.64 Million USD | -4161.465% |
| Iterum Therapeutics plc | -47.46 Million USD | -945.346% |